Corcept Therapeutics (CORT) Other Gross PP&E Adjustments (2016 - 2025)
Corcept Therapeutics (CORT) has disclosed Other Gross PP&E Adjustments for 14 consecutive years, with -$32.4 million as the latest value for Q4 2025.
- Quarterly Other Gross PP&E Adjustments fell 385.24% to -$32.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$32.4 million through Dec 2025, down 385.24% year-over-year, with the annual reading at -$32.4 million for FY2025, 385.24% down from the prior year.
- Other Gross PP&E Adjustments hit -$32.4 million in Q4 2025 for Corcept Therapeutics, down from -$5.2 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.2 million in Q1 2023 to a low of -$32.4 million in Q4 2025.
- Historically, Other Gross PP&E Adjustments has averaged -$3.7 million across 5 years, with a median of -$1.3 million in 2023.
- Biggest YoY gain for Other Gross PP&E Adjustments was 806.42% in 2021; the steepest drop was 1747.26% in 2021.
- Year by year, Other Gross PP&E Adjustments stood at -$15.2 million in 2021, then surged by 106.15% to $932000.0 in 2022, then crashed by 369.42% to -$2.5 million in 2023, then tumbled by 166.11% to -$6.7 million in 2024, then crashed by 385.24% to -$32.4 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for CORT at -$32.4 million in Q4 2025, -$5.2 million in Q3 2025, and -$5.6 million in Q2 2025.